1. Volume 9, Issue 6, Pages 556-562 (June 2017)
Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury 
Mithra B. Maneyapanda, MD, Zachary L. McCormick, MD, Christina Marciniak, MD, Christopher Reger, MD 
PM&R 
Volume 9, Issue 6, Pages (June 2017)
DOI: /j.pmrj
Copyright © 2017 American Academy of Physical Medicine and Rehabilitation Terms and Conditions

2. Figure 1
Dose stability of intrathecal baclofen at long-term follow-up. Intrathecal baclofen dose over time in (A) traumatic brain injury, (B) stroke, and (C) hypoxic-ischemic encephalopathy. Each colored line represents an individual patient. *This patient had ITB for 13 years and large dose changes in the years before the time of study. His ITB dose was decreased due to stable spasticity and suspected catheter malfunction. His spasticity remained stable with a lower dose and the patient underwent catheter revision. He was noted to have a gradual increase in spasticity and subsequent increases in ITB dosage. ITB = intrathecal baclofen.
PM&R 2017 9, DOI: ( /j.pmrj )
Copyright © 2017 American Academy of Physical Medicine and Rehabilitation Terms and Conditions